Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

Zorac introduced in U.K. for psoriasis

Oct. 22, 1997

Peptech and Allergan terminate collaboration on GMDP

Oct. 20, 1997

Integra Artificial Skin receives approval in Taiwan

Oct. 16, 1997

Amarillo Biosciences licenses cytokines from Hayashibara

Oct. 14, 1997

Basic tissue regeneration patent issued to The Burnham Institute

Oct. 14, 1997

Dermagraft launched in the U.K.

Oct. 8, 1997

Interim phase III results reported for BCX-34

Oct. 3, 1997

Apligraf burn study results presented at scientific symposium

Sep. 29, 1997

Celgene's thalidomide approvable for ENL

Sep. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...